V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20161372 | 20062379 | 1.66 | 85.1 | Neo-adjuvant (N) | 2018-02-19 | 2018-02-23 | ECX | 02 | N | ECX | 100768154 |
| 20161373 | 20062380 | null | null | Palliative (P) | 2017-09-23 | 2017-10-07 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101643450 |
| 20161377 | 20062381 | 1.63 | 64.4 | Neo-adjuvant (N) | 2017-10-12 | 2017-10-30 | ECX | N | N | ECX | 101086605 |
| 20161378 | 20062382 | 1.8 | 93 | null | 2017-02-13 | 2017-02-25 | ECX | null | Y | CAPECITABINE + GEMCITABINE | 101262965 |
| 20161379 | 20062383 | 1.76 | 90 | null | 2019-05-18 | 2019-05-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101071824 |
| 20161380 | 20062384 | 1.63 | 80 | Neo-adjuvant (N) | 2016-07-23 | 2016-08-07 | ECX | N | Y | ECX | 100669472 |
| 20161382 | 20062385 | 1.78 | 65.9 | Neo-adjuvant (N) | 2017-02-24 | 2017-02-25 | ECX | 02 | N | ECX | 101139338 |
| 20161383 | 20062386 | 1.7 | 70.3 | null | 2017-03-09 | 2017-03-20 | Gemcitabine + Capecitabine | N | N | ECX | 101565436 |
| 20161384 | 20062387 | 1.66 | 55.8 | Palliative (P) | 2019-02-08 | 2019-02-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101579765 |
| 20161385 | 20062388 | 1.61 | 58.5 | Neo-adjuvant (N) | 2018-12-22 | 2018-12-31 | ECX | N | null | ECX | 100046346 |
| 20161387 | 20062389 | 1.82 | 110 | 03 | 2019-12-30 | 2019-12-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100359984 |
| 20161389 | 20062390 | null | 89.6 | null | 2018-03-10 | 2018-04-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100046984 |
| 20161390 | 20062391 | 1.77 | 65.5 | Palliative (P) | 2017-06-11 | 2017-07-19 | ECX | N | N | ECX | 101293301 |
| 20161391 | 20062392 | 1.65 | 58.9 | Palliative (P) | 2018-04-22 | 2018-05-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100240531 |
| 20161394 | 20062393 | 1.68 | 86.9 | Neo-adjuvant (N) | 2018-07-16 | 2018-07-29 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100884627 |
| 20161395 | 20062394 | 1.62 | 90 | Palliative (P) | 2017-08-27 | 2017-08-28 | ECX | 02 | N | ECX | 100842370 |
| 20161396 | 20062395 | null | null | Neo-adjuvant (N) | 2019-11-25 | 2019-11-25 | ECX | 02 | N | ECX | 100546498 |
| 20161397 | 20062396 | 1.74 | 90 | Adjuvant (A) | 2018-09-19 | 2018-10-12 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100887588 |
| 20161400 | 20062397 | 1.7 | 103.4 | Adjuvant (A) | 2017-02-21 | 2017-03-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101233828 |
| 20161405 | 20062398 | 1.58 | 102.2 | Neo-adjuvant (N) | 2020-01-02 | 2020-01-13 | ECX | N | null | ECX | 101232354 |
| 20161407 | 20062399 | 1.69 | 98.2 | Neo-adjuvant (N) | 2016-05-26 | 2016-06-13 | ECX | N | N | ECX | 101004318 |
| 20161408 | 20062400 | 1.82 | 49.4 | null | 2018-04-13 | 2018-04-27 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101059972 |
| 20161409 | 20062401 | 1.7 | 74 | Neo-adjuvant (N) | 2017-05-26 | 2017-06-03 | ECX | N | N | ECX | 100826232 |
| 20161410 | 20062402 | 1.59 | 82.3 | Neo-adjuvant (N) | 2018-08-06 | 2018-08-13 | ECX | N | N | ECX | 101142126 |
| 20161411 | 20062403 | 1.72 | 61.9 | Adjuvant (A) | 2016-11-24 | 2016-12-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100523732 |
| 20161413 | 20062404 | 1.54 | 109.3 | Neo-adjuvant (N) | 2019-06-08 | 2019-06-26 | ECX | 02 | N | ECX | 101578381 |
| 20161415 | 20062405 | 1.8 | 102 | Palliative (P) | 2017-05-30 | 2017-06-07 | ECX | N | N | ECX | 100329939 |
| 20161416 | 20062406 | 1.72 | 86 | Adjuvant (A) | 2016-12-15 | 2016-12-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101507054 |
| 20161417 | 20062407 | 1.83 | 89.9 | Palliative (P) | 2020-03-17 | 2020-03-20 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100618618 |
| 20161421 | 20062408 | 1.66 | 72 | Neo-adjuvant (N) | 2019-08-30 | 2019-09-06 | ECX | 02 | N | ECX | 101650181 |
| 20161423 | 20062409 | 1.7 | 97.7 | Adjuvant (A) | 2018-11-29 | 2018-12-27 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101473170 |
| 20161425 | 20062410 | 1.67 | 73.35 | Adjuvant (A) | 2018-09-28 | 2018-10-23 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100124786 |
| 20161427 | 20062411 | 1.77 | 69.4 | Palliative (P) | 2018-01-28 | 2018-01-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101746865 |
| 20161428 | 20062412 | 1.83 | 70.95 | Palliative (P) | 2019-02-28 | 2019-02-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101223366 |
| 20161431 | 20062413 | 1.66 | 54.6 | Adjuvant (A) | 2017-04-21 | 2017-04-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101262798 |
| 20161432 | 20062414 | 1.8 | 78.4 | null | 2017-07-25 | 2017-08-20 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101088436 |
| 20161434 | 20062415 | 1.75 | 73.2 | null | 2016-02-14 | 2016-02-29 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100197377 |
| 20161437 | 20062416 | 1.75 | 75.7 | Neo-adjuvant (N) | 2016-02-13 | 2016-02-25 | ECX | N | N | ECX | 100986402 |
| 20161439 | 20062417 | 1.65 | 126.2 | Adjuvant (A) | 2019-07-25 | 2019-07-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100949761 |
| 20161440 | 20062418 | 1.67 | 73.5 | Palliative (P) | 2017-08-11 | 2017-08-24 | ECX | N | N | ECX | 101602719 |
| 20161441 | 20062419 | 1.64 | 86 | Neo-adjuvant (N) | 2017-04-08 | 2017-04-08 | ECX | 02 | N | ECX | 101031124 |
| 20161444 | 20062420 | 1.6 | 89 | null | null | 2019-07-11 | Gemcitabine + Capecitabine | 01 | N | CAPECITABINE + GEMCITABINE | 101104864 |
| 20161446 | 20062421 | 1.65 | 70 | Neo-adjuvant (N) | 2017-11-11 | 2017-11-22 | ECX | N | N | ECX | 100623849 |
| 20161447 | 20062422 | null | null | Adjuvant (A) | 2017-07-12 | 2017-07-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100636475 |
| 20161448 | 20062423 | 1.77 | 70.6 | null | 2019-06-27 | 2019-06-27 | ECX | N | null | ECX | 100723753 |
| 20161451 | 20062424 | 1.8 | 71.3 | null | 2018-06-16 | 2018-06-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101775977 |
| 20161452 | 20062425 | 1.7 | 83.1 | Curative (C) | 2019-09-16 | 2019-09-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101536220 |
| 20161455 | 20062426 | 1.93 | 75.3 | Neo-adjuvant (N) | 2019-06-29 | 2019-07-12 | ECX | N | N | ECX | 101510899 |
| 20161456 | 20062427 | 1.5 | 73 | Adjuvant (A) | 2016-07-08 | 2016-07-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101319617 |
| 20161458 | 20062428 | 1.42 | 72.25 | Neo-adjuvant (N) | 2019-11-08 | 2019-11-10 | ECX | 02 | N | ECX | 101448755 |